Medicine Description atrabesylate 25 mg
Atrabesylate 25 mg 5 injections is a medication that acts as a neuromuscular blocker by competing with acetylcholine for binding at the neuromuscular junction. It specifically inhibits the action of acetylcholine on nicotinic receptors at the motor end plate, which leads to a reduction in muscle contraction. This mechanism results in muscle paralysis for the duration of its action, making it particularly useful in surgical settings where muscle relaxation is necessary. The drug is metabolized by non-specific plasma esterases and is favorably eliminated through a combination of spontaneous degradation and Hoffman elimination, which is dependent on pH and temperature, making it suitable for patients with renal or hepatic impairment. This dual elimination pathway ensures that Atracurium Besylate can be utilized effectively in various clinical conditions with minimal risk of accumulation.
Indications and Uses of Atrabesylate 25 mg 5 injections
- Facilitation of tracheal intubation in anesthetic procedures
- Muscle relaxation during surgical interventions
- Assistance in mechanical ventilation
Side Effects of Atrabesylate 25 mg 5 injections
- Hypotension
- Bradycardia
- Allergic reactions
- Respiratory depression
- Prolonged neuromuscular block
Storage and Handling
Atrabesylate should be stored in a cool, dry place away from light. It is important to maintain the medication at temperatures between 2 to 8 degrees Celsius. Protect it from freezing and ensure that it is kept out of reach of children.
Patient Advice and Precautions
Inform healthcare providers of any allergies or medical conditions before using this medication.Ensure that emergency resuscitation equipment is available whenever Atrabesylate is administered.Monitor respiratory function and neuromuscular status during and after administration.Use with caution in patients with cardiovascular diseases.